Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jul 25:15:04166.
doi: 10.7189/jogh.15.04166.

Global geographic and socioeconomic disparities in COVID-associated acute kidney injury: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Global geographic and socioeconomic disparities in COVID-associated acute kidney injury: a systematic review and meta-analysis

Danyang Dai et al. J Glob Health. .

Abstract

Background: Acute kidney injury (AKI) is a common and severe complication of COVID-19, which significantly increases the risk of mortality. There has been a wide range of AKI prevalence reported throughout the pandemic, reflecting differences in geographic location, patient characteristics, and health care resources. We aimed to provide a global overview of the COVID-19 AKI prevalence reported in published studies to uncover geographic and socioeconomic disparities.

Methods: We undertook a systematic review and meta-analysis, searching PubMed, Embase, Scopus, Web of Science, and Cochrane Library for full-text articles published in English reporting the prevalence of AKI from January 2020 to November 2023. All studies defined AKI according to the Kidney Disease Improving Global Outcomes criteria. Clinical characteristics were extracted and examined from 334 studies that met the inclusion criteria. With significant study heterogeneity, random-effect models were estimated. We reported pooled AKI prevalence by country, region, and income level. Meta-regression further examined the relationship between COVID-associated AKI and geographic location.

Results: After removing studies that utilised the same data, 345 796 patients from 246 studies were included, covering 49 countries. Of 246 studies, 137 came from high-income countries, whereas only three were conducted in low-income countries. Among non-intensive care unit (ICU) patients, low-income countries had the lowest COVID-19 AKI prevalence (14.1%; 95% confidence interval (CI) = 11.4-17.2). Among ICU patients, lower-middle-income countries had the lowest COVID-19 AKI prevalence (27.9%;95% CI = 19.4-38.4).

Conclusions: Our study shows significant geographic and socioeconomic disparities in the prevalence of COVID-associated AKI, with a higher prevalence in high-income countries and a lower prevalence in low- and lower-middle-income countries. This study is the most comprehensive systematic review and meta-analysis highlighting global disparities in COVID-associated AKI prevalence. Further studies are needed to explain the reasons behind these differences.

PubMed Disclaimer

Conflict of interest statement

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.

Figures

Figure 1
Figure 1
PRISMA flowchart. *Studies that included patients age <18, kidney transplanted patients, only survival patients or only death patients. †Studies that were randomised control trails, drug test related studies, studies that used propensity score matching.
Figure 2
Figure 2
Pooled AKI prevalence for non-ICU patients by income level and region. AKI – acute kidney injury, ICU – intensive care unit.
Figure 3
Figure 3
Pooled AKI prevalence for ICU patients by income level and region. AKI – acute kidney injury, ICU – intensive care unit.

Similar articles

References

    1. Palevsky PM.COVID-19 and AKI: Where Do We Stand? J Am Soc Nephrol. 2021;32:1029-32. 10.1681/ASN.2020121768 - DOI - PMC - PubMed
    1. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209-18. 10.1016/j.kint.2020.05.006 - DOI - PMC - PubMed
    1. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-38. 10.1016/j.kint.2020.03.005 - DOI - PMC - PubMed
    1. Fu EL, Janse RJ, de Jong Y, van der Endt VHW, Milders J, van der Willik EM, et al. Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis. Clin Kidney J. 2020;13:550-63. 10.1093/ckj/sfaa160 - DOI - PMC - PubMed
    1. Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021;32:151-60. 10.1681/ASN.2020050615 - DOI - PMC - PubMed